Levefix 500 mg Tablet

Levefix 500 mg Tablet সম্পর্কে

বাংলাদেশে Levefix 500 mg Tablet ট্যাবলেট হিসেবে পাওয়া যায়; এতে Levetiracetam আছে (৫০০ mg)। Levetiracetam-এর অন্য ব্র্যান্ডগুলো এই পাতায় কম দাম থেকে সাজানো আছে, দাম তুলনা করতে পারবেন। Levefix 500 mg-এর প্রতি ইউনিটের দাম ৩০ টাকা। এই ব্র্যান্ডের প্রস্তুতকারক Opsonin Pharma Limited। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।

Levetiracetam-এর ৩৪টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। এর চেয়ে কম ইউনিট দামের ব্র্যান্ড আছে ২টি। সবচেয়ে কম দাম Citazar 250 mg Tablet-এর, প্রতি ইউনিট ৳ ১৫.১১।

Levefix 500 mg Tablet কী?

Levefix 500 mg comes as a tablet with 500 mg of Levetiracetam, from Opsonin Pharma Limited. It belongs to a group called adjunct anti-epileptic drugs. The tablet is given by a healthcare professional. Always follow the prescription and do not change anything without medical advice.

Levefix 500 mg-এর ব্যবহার

In some adults and adolescents it can be used alone, and in other age groups it is used together with other anti-epileptic medicines. Levefix 500 mg 500 mg tablet is used to treat partial-onset seizures, which are seizures that begin in one part of the brain and may or may not spread to the whole body. It is prescribed for certain seizure types; the doctor decides which seizures it is suitable for and whether it is given alone or with other medicines. Your doctor will determine if this medicine is suitable for your condition.

Levefix 500 mg কীভাবে ব্যবহার করবেন

Keep a regular routine and attend follow-up visits so your doctor can review how the treatment is working. Swallow the tablet with water. Levefix 500 mg is taken by mouth. Shake the bottle well before each use. The doctor decides the dose, how often to take it and how long the course should continue, and this may be adjusted over time. Do not stop suddenly, because stopping epilepsy medicine too quickly can be harmful.

Levefix 500 mg-এর পার্শ্বপ্রতিক্রিয়া

Contact the doctor if a side effect bothers you or does not settle. In children, the most common include tiredness, aggression, nasal congestion, decreased appetite and irritability.

সতর্কতা ও নিরাপত্তা

Levetiracetam is not recommended during pregnancy and in women who could become pregnant and are not using contraception, unless the doctor considers it clinically necessary. It passes into breast milk, so breastfeeding is generally not recommended; discuss this with the doctor. Ask your doctor first if you have had an allergic reaction to Levetiracetam or similar medicines.

সাধারণ প্রশ্ন

What is Levefix 500 mg used for?

In some adults and adolescents it can be used alone, and in other age groups it is used together with other anti-epileptic medicines. Levefix 500 mg 500 mg tablet is used to treat partial-onset seizures, which are seizures that begin in one part of the brain and may or may not spread to the whole body.

How is Levefix 500 mg used?

Keep a regular routine and attend follow-up visits so your doctor can review how the treatment is working. Swallow the tablet with water.

What should I watch for while using Levefix 500 mg?

Contact the doctor if a side effect bothers you or does not settle. In children, the most common include tiredness, aggression, nasal congestion, decreased appetite and irritability.

Can I use Levefix 500 mg in pregnancy or while breastfeeding?

Levetiracetam is not recommended during pregnancy and in women who could become pregnant and are not using contraception, unless the doctor considers it clinically necessary. It passes into breast milk, so breastfeeding is generally not recommended; discuss this with the doctor.

Tablet
জেনেরিক নাম
Levetiracetam
শক্তি
500 mg
ডোজ ফর্ম
Tablet
প্রস্তুতকারক
Opsonin Pharma Limited
বাংলাদেশে দাম

৳ ২৯.৪ ৳ ৩০ ২% ছাড় প্রতি ইউনিট

দাম হালনাগাদ: ১৬ Nov ২০২৬

নির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Levetiracetam is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed epilepsy. Levetiracetam is indicated as adjunctive therapy-
  • in the treatment of partial-onset seizures with or without secondary generalization in adults, adolescents, children and infants from 1 month of age with epilepsy.
  • ... Read more
Levetiracetam is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed epilepsy. Levetiracetam is indicated as adjunctive therapy-
  • in the treatment of partial-onset seizures with or without secondary generalization in adults, adolescents, children and infants from 1 month of age with epilepsy.
  • in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.
  • in the treatment of primary generalized tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.

মাত্রা ও সেবনবিধি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Adults and adolescents from 16 years of age: The recommended starting dose is 250 mg twice daily which should be increased to an initial therapeutic dose of 500 mg twice daily after two weeks. The dose can be further increased by 250 mg twice daily every two weeks depending upon the clinical response. The maximum dose is 1500 mg twice daily.

Adults (≥18 years) and adolescents (12 to 17 years) weighing 50 kg or more: The initial therapeutic dose is 500 mg twice daily. This dose can be started on the first day of treatment. Depending upon the clinical response and tolerability, the daily dose can be increased up to 1,500 mg twice daily. Dose changes can be made in 500 mg twice daily increases or decrease every two to four weeks.

Pediatric population: The tablet formulation is not adapted for use in infants and children under the age of 6 years. Oral solution is the preferred formulation for use in this population. In addition, the available dose strengths of the tablets are not appropriate for initial treatment in children weighing less than 25 kg, for patients unable to swallow tablets or for the administration of doses below 250 mg. In all of the above cases, oral solution should be used.

  • Monotherapy: The safety and efficacy of levetiracetam in children and adolescents below 16 years as monotherapy treatment have not been established.
  • Add-on therapy: Oral solution is the preferred formulation for use in infants and children under the age of 6 years. For children 6 years and above, oral solution should be used for doses under 250 mg, for doses not in multiples of 250 mg when dosing recommendation is not achievable by taking multiple tablets and for patients unable to swallow tablets. The lowest effective dose should be used. The starting dose for a child or adolescent of 25 kg should be 250 mg twice daily with a maximum dose of 750 mg twice daily. Dosing for children 50 kg or greater is the same as in adults.
  • Add-on therapy: For infants aged from 1 month to less than 6 months: The oral solution is the formulation to use in infants.

ঔষধের মিথষ্ক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Antiepileptic medicinal products: Pre-marketing data from clinical studies conducted in adults indicate that levetiracetam did not influence the serum concentrations of existing antiepileptic medicinal products (phenytoin, carbamazepine, valproic acid, phenobarbital, lamotrigine, gabapentin and primidone) and that these antiepileptic medicinal products did not influence the pharmacokinetics of levetiracetam.

Probenecid: Probenecid (500 mg four times daily), a renal tubular secretion blocking agent, has been shown to inhibit the renal clearance of the primary metabolite but not of levetiracetam. Nevertheless, the concentration of this metabolite remains low.

Methotrexate: Concomitant administration of levetiracetam and methotrexate has been reported to decrease methotrexate clearance, resulting in increased/prolonged blood methotrexate concentration to potentially toxic levels. Blood methotrexate and levetiracetam levels should be carefully monitored in patients treated concomitantly with the two drugs.

Laxatives: There have been isolated reports of decreased levetiracetam efficacy when the osmotic laxative macrogol has been concomitantly administered with oral levetiracetam. Therefore, macrogol should not be taken orally for one hour before and for one hour after taking levetiracetam.

Food and alcohol: The extent of absorption of levetiracetam was not altered by food, but the rate of absorption was slightly reduced. No data on the interaction of levetiracetam with alcohol are available.

প্রতিনির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Hypersensitivity to the active substance or other pyrrolidone derivatives or to any of the excipients.

পার্শ্ব প্রতিক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Most common adverse reactions (incidence ≥ 5% more than placebo) include:
  • Adult patients: somnolence, asthenia, infection and dizziness
  • Pediatric patients: fatigue, aggression, nasal congestion, decreased appetite, and irritability

গর্ভাবস্থায় ও স্তন্যদানকালে

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Levetiracetam is not recommended during pregnancy and in women of childbearing potential not using contraception unless clinically necessary. Levetiracetam is excreted in human breast milk. Therefore, breastfeeding is not recommended. However, if levetiracetam treatment is needed during breastfeeding, the benefit/risk of the treatment should be weighed considering the importance of breastfeeding. No impact on fertility was detected in animal studies. No clinical data are available, the potential risk for humans is unknown.

সতর্কতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Renal impairment: The administration of levetiracetam to patients with renal impairment may require dose adjustment. In patients with severely impaired hepatic function, assessment of renal function is recommended before dose selection.

Acute kidney injury: The use of levetiracetam has been very rarely associated with acute kidney injury with a time to onset ranging from a few days to several months.

Blood cell counts: Rare cases of decreased blood cell counts (neutropenia, agranulocytosis, leucopenia, thrombocytopenia and pancytopenia) have been described in association with levetiracetam administration, generally at the beginning of the treatment. Complete blood cell counts are advised in patients experiencing important weakness, pyrexia, recurrent infections or coagulation disorders.

Suicide: Suicide, suicide attempt, suicidal ideation and behaviour have been reported in patients treated with anti-epileptic agents (including levetiracetam). A meta-analysis of randomized placebo-controlled trials of anti-epileptic medicinal products has shown a small increased risk of suicidal thoughts and behaviour. The mechanism of this risk is not known. Therefore patients should be monitored for signs of depression and/or suicidal ideation and behaviours and appropriate treatment should be considered. Patients (and caregivers of patients) should be advised to seek medical advice should signs of depression and/or suicidal ideation or behaviour emerge.

Paediatric population: The tablet formulation is not adapted for use in infants and children under the age of 6 years. Available data in children did not suggest an impact on growth and puberty. However, long term effects on learning, intelligence, growth, endocrine function, puberty and childbearing potential in children remain unknown.

মাত্রাধিক্যতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Somnolence, agitation, aggression, depressed level of consciousness, respiratory depression and coma were observed with levetiracetam overdoses. After an acute overdose, the stomach may be emptied by gastric lavage or by induction of emesis. There is no specifc antidote for levetiracetam. Treatment of an overdose will be symptomatic and may include haemodialysis. The dialyser extraction efficiency is 60 % for levetiracetam and 74% for the primary metabolite.

সংরক্ষণ

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Store at a cool temperature (not exceeding 25°C) and dry place, protected from light.

বিকল্প ব্র্যান্ড: Levetiracetam

একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।

Citazar Tablet

250 mg

Levetiracetam

Advanced Chemical Industries PLC

৳ ১৪.৮১ ৳ ১৫.১১ ২% ছাড় প্রতি ইউনিট

Iracet Tablet

250 mg

Levetiracetam

Square Pharmaceuticals PLC.

৳ ১৫.৬৮ ৳ ১৬.০০ ২% ছাড় প্রতি ইউনিট

Citazar Tablet

500 mg

Levetiracetam

Advanced Chemical Industries PLC

৳ ২৯.৪ ৳ ৩০.০০ ২% ছাড় প্রতি ইউনিট

Iracet Tablet

500 mg

Levetiracetam

Square Pharmaceuticals PLC.

৳ ৩১.৩৬ ৳ ৩২.০০ ২% ছাড় প্রতি ইউনিট

Citazar Suspension

100 mg/ml

Levetiracetam

Advanced Chemical Industries PLC

দাম দেওয়া নেই

Citazar Tablet

1000 mg

Levetiracetam

Advanced Chemical Industries PLC

দাম দেওয়া নেই

Citazar Tablet

750 mg

Levetiracetam

Advanced Chemical Industries PLC

দাম দেওয়া নেই

Citazar Iv Injection

500 mg/5 ml

Levetiracetam

Advanced Chemical Industries PLC

দাম দেওয়া নেই

সব দেখুন ৩৪ ব্র্যান্ড

ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।